Skip to main content
Dryad

Data from: Gal-1 promotes lung cancer cell survival by enhancing PARP1/H1.2 interaction to promote DNA repair upon DNA damage response

Data files

May 23, 2025 version files 210.33 MB

Click names to download individual files

Abstract

Galectin-1 (Gal-1), a member of the galectin family, has emerged as a regulator of tumor progression. Several studies have reported the up-regulation of Gal-1 expression in multiple cancer cells and its promotion on tumor proliferation. However, the mechanism by which Gal-1 promotes tumor growth remains to be thoroughly understood. In this study, it was discovered that high expression of Gal-1 in viral cancers was inversely correlated with the overall survival of patients. Through constructing Gal-1-overexpressing cell lines, it was uncovered that cell proliferation and colony formation were significantly improved. The results of transcriptomic and proximity-labeling-based proteomic analyses indicated that Gal-1 interacted with PARP1 and histone H1.2 in lung cancer cells. In the case of etoposide treatment leading to DNA double-strand breaks, Gal-1 accelerated the degradation of H1.2 by enhancing its interaction with PARP1 and promoting its PARylation modification. It caused the activation of downstream DNA repair pathways such as the ATM and NBS1 signaling pathways, thus reducing apoptosis. Moreover, Gal-1 inhibitors TDG and OTX008 could restore cell sensitivity to etoposide. This study provides new clues for the role of Gal-1 in the development of tumors and renders suggestions for the treatment of patients with high Gal-1 expression in the clinic.